OPKO Health, Inc. Forecast, price target & analysts
OPKO Health, Inc. Target price 2025 - Analyst rating & recommendation
OPKO Health, Inc. Classifications & Recommendation:
OPKO Health, Inc. Price Target
| Target Price | $3.96 |
| Price | $1.63 |
| Potential |
142.84%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target OPKO Health, Inc. 2026 .
The average OPKO Health, Inc. target price is $3.96.
This is
142.84%
register free of charge
$8.50
421.47%
register free of charge
$2.00
22.70%
register free of charge
|
|
| A rating was issued by 6 analysts: 6 Analysts recommend OPKO Health, Inc. to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the OPKO Health, Inc. stock has an average upside potential 2026 of
142.84%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Million $ | 863.50 | 684.92 |
| 14.01% | 20.68% | |
| EBITDA Margin | -6.11% | -20.76% |
| 55.37% | 239.77% | |
| Net Margin | -19.76% | -16.94% |
| 36.80% | 14.27% |
6 Analysts have issued a sales forecast OPKO Health, Inc. 2024 . The average OPKO Health, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an OPKO Health, Inc. EBITDA forecast 2024. The average OPKO Health, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast OPKO Health, Inc. 2024 . The average OPKO Health, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.25 | -0.17 |
| 45.65% | 32.00% | |
| P/E | negative | |
| EV/Sales | 1.81 |
1 Analysts have issued a OPKO Health, Inc. forecast for earnings per share. The average OPKO Health, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the OPKO Health, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
OPKO Health, Inc....
Current OPKO Health, Inc. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Jan 08 2025 |
| Barrington Research | Locked ➜ Locked | Locked | Nov 08 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Sep 26 2024 |
| Barrington Research | Locked ➜ Locked | Locked | Sep 20 2024 |
| HC Wainwright & Co. | Locked ➜ Locked | Locked | Sep 17 2024 |
| Piper Sandler | Locked ➜ Locked | Locked | Sep 17 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Jan 08 2025 |
|
Locked
Barrington Research: Locked ➜ Locked
|
Nov 08 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Sep 26 2024 |
|
Locked
Barrington Research: Locked ➜ Locked
|
Sep 20 2024 |
|
Locked
HC Wainwright & Co.: Locked ➜ Locked
|
Sep 17 2024 |
|
Locked
Piper Sandler: Locked ➜ Locked
|
Sep 17 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
